Scientist, Biologics Analytical Development

Nektar Therapeutics San Francisco , CA 94118

Posted 2 months ago

This role will be responsible for product characterization, analytical method development/validation of proteins and protein-conjugates for Nektar Biologic products in pre-clinical and clinical development stages. Conducts and collaborates with others on analytical issues relevant to long-term objectives and concerns.

Develops testing methodologies to support process development of drug substance and drug product. This position contributes to and supports the company's research development and manufacturing to create high value therapeutics to address unmet medical needs.

The successful candidate will be responsible for:

  • Developing and validating analytical methods to support early stage drug development activities

  • Characterization of protein polymer conjugates to elucidate conjugate sites and distribution

  • Assist Process Development Scientists in characterizing and monitoring in-process purification

  • Transfering analytical methods to internal QC group or CROs for drug substance and drug product release testing

  • Summarizing experimental data and writing technical reports

Additional responsibilities include: Using professional concepts and company's policies and procedures to solve a wide range of difficult problems in imaginative and practical ways.

May determine methods and procedures on new assignments and recommend new methods and procedures. Communicate cross-functionally with groups such as Research, Process Development, Formulation Development, Manufacturing, QC group and CRO/CMOs to ensure appropriate project support. Maintain current knowledge of latest technological/scientific trends.

Requirements:

Requires a PhD in a scientific discipline and a minimum of 2 years related experience, may include post-doctoral experience. Exceptional non-PhDs with demonstrated capabilities and/or significant experience may also be considered.

Must have in-depth knowledge and hands-on experience in analytical method development and characterization for biologics Must have extensive experience in different HPLC separation methods such as ion exchange, reversed phase, and size exclusion chromatography for proteins. Must be able to demonstrate potential for technical proficiency, scientific creativity, collaboration with others and independent thought. Must be able to clearly communicate scientific information both written and oral.

Experience in mass spectrometry and capillary electrophoresis analysis of proteins is highly desirable. Works on problems of moderate scope in which analysis of situation or data requires a review of identifiable factors. Experience in technology transfer to internal QC lab or CRO in support of drug substance/drug product release testing is highly desirable.

Good computer skills are required. Working knowledge of MS word, Excel, Power point is a plus. Must be willing to work as part of a team.



icon no score

See how you match
to the job

Find your dream job anywhere
with the LiveCareer app.
Mobile App Icon
Download the
LiveCareer app and find
your dream job anywhere
App Store Icon Google Play Icon
lc_ad

Boost your job search productivity with our
free Chrome Extension!

lc_apply_tool GET EXTENSION

Similar Jobs

Want to see jobs matched to your resume? Upload One Now! Remove
Principal Scientist Analytical Development

Allogene Therapeutics, Inc.

Posted 3 days ago

VIEW JOBS 4/18/2019 12:00:00 AM 2019-07-17T00:00 Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, Allogene is developing a pipeline of "off-the-shelf" CAR T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients. AlloCAR T™ cell therapies are engineered from cells of healthy donors, which is intended to allow for creation of inventory for on demand use in patients. This approach is designed to eliminate the need to create personalized therapy from a patient's own cells, simplify manufacturing, and reduce the time patients must wait for CAR T cell treatment. The Allogene portfolio includes rights to 16 pre-clinical CAR T cell therapy targets and UCAT19, an AlloCAR T™ therapy candidate currently in Phase 1 sponsored by Servier for the treatment of relapsed/refractory acute lymphoblastic leukemia (ALL). For more information, please visit www.allogene.com, and follow @AllogeneTx on Twitter and LinkedIn. Job Description: We are seeking a highly motivated technical leader to join Allogene's Process and Product Development organization to lead the analytical development activities for a companion monoclonal antibody that is administered prior to treatment with AlloCART therapy. This leader will guide and oversee all aspects of analytical technical development activities at a CDMO, and other third-parties as necessary, including development of QTPP and robust analytical methods in support of the analytical control strategy and successful BLA filing. Responsibilities include, but are not limited to: * Leadership and oversight of analytical technical activities at a CDMO in support of drug substance/ drug product development and Registration on accelerated timelines, including late-stage process/ product characterization, risk assessments, and establishment of QTPP and control of CQAs * Scientific understanding and oversight of development and performance robustness of analytical methods (e.g. for aggregates, fragments, charge variants, chemical modifications, and other product-related substances and impurities) for in-process, release and stability testing for a late stage biologics development program * Ability to establish and maintain a strong working collaboration with CDMO and other partner groups * Analysis and critical evaluation of analytical data, including technical review of reports authored at CDMO * Preparation and/or review of documents in support of CMC Regulatory BLA/ MAA filings and addressing queries from health authorities * Regular refreshment of activities plan for efficiency and speed to ensure timelines are maintained * Communication of activities to internal stakeholders to ensure understanding and alignment with regard to status and risks Position Requirements & Experience: * PhD or MS in analytical sciences, biotechnology, pharmaceutical sciences, biochemistry, or equivalent life sciences field with at least 8+ years (with PhD) or 12+ years (with MS) of experience in late-stage analytical development for recombinant protein therapeutics. * Excellent organizational skills and an ability to prioritize effectively to deliver results within aggressive timelines * Strong collaboration and interpersonal skills, including verbal and written communication, and ability influence * Ability to work independently and as part of a matrixed team * This position will require ability to travel to/ spend time at CDMO site(s) * Candidates must be authorized to work in the U.S. As an equal opportunity employer, Allogene Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact the careers email at www.allogene.com for assistance. For more information about equal employment opportunity protections, please view the 'EEO is the Law' poster. #LI-EL1 Allogene Therapeutics, Inc. South San Francisco CA

Scientist, Biologics Analytical Development

Nektar Therapeutics